◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

REGENERON PHARMACEUTICALS, INC.

CIK: 872589 SIC: 2834
$14.34B
Revenue
$4.50B
Net Income
85.35%
Gross Margin
24.95%
Op. Margin
$6.64B
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 16 annual reports available (2010 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $14.34B $14.34B $14.20B $13.12B $12.17B $16.07B
Revenue Growth % 0.0% 1.0% 8.3% 7.8% -24.3% nan%
Cost of Revenue $2.10B $2.10B $1.97B $1.82B $1.56B $2.44B
+ Gross Profit $12.24B $12.24B $12.23B $11.30B $10.61B $13.63B
Gross Margin % 85.4% 85.4% 86.1% 86.2% 87.2% 84.8%
Operating Expenses $10.77B $10.77B $10.21B $9.07B $7.43B $7.12B
Research & Development $5.85B $5.85B $5.13B $4.44B $3.59B $2.91B
Selling General & Admin $2.70B $2.70B $2.95B $2.63B $2.12B $1.82B
+ Operating Income $3.58B $3.58B $3.99B $4.05B $4.74B $8.95B
Operating Margin % 24.9% 24.9% 28.1% 30.9% 38.9% 55.7%
Interest Expense $41.60M $41.60M $52.60M $73.00M $59.40M $57.30M
Other Income/Expense $1.70B $1.70B $844.40M $225.20M $179.30M $436.30M
Income Before Tax $5.23B $5.23B $4.78B $4.20B $4.86B $9.33B
Income Tax Expense $725.80M $725.80M $367.30M $245.70M $520.40M $1.25B
+ Net Income $4.50B $4.50B $4.41B $3.95B $4.34B $8.08B
Net Margin % 31.4% 31.4% 31.1% 30.1% 35.6% 50.2%
Basic EPS nan 43.07 40.90 37.05 40.51 76.40
Diluted EPS nan 41.48 38.34 34.77 38.22 71.97
Basic Shares Outstanding -500K 104.6M 107.9M 106.7M 107.1M 105.7M
Diluted Shares Outstanding -300K 108.6M 115.1M 113.7M 113.5M 112.2M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $3.12B $2.49B $2.73B $3.11B $2.89B
Short-term Investments $5.49B $6.52B $8.11B $4.64B $2.81B
Accounts Receivable $5.74B $6.21B $5.67B $5.33B $6.04B
Inventory $3.20B $3.09B $2.58B $2.40B $1.95B
Other Current Assets $474.80M $349.20M $386.60M $411.20M $332.40M
Total Current Assets $18.02B $18.66B $19.48B $15.88B $14.01B
Intangible Assets $1.26B $1.15B $1.04B $915.50M $6.70M
Long-term Investments $10.26B $8.90B $5.40B $6.59B $6.84B
Other Non-current Assets $1.82B $1.14B $444.10M $336.40M $222.80M
Total Assets $40.56B $37.76B $33.08B $29.21B $25.43B
Accounts Payable $939.00M $789.50M $606.60M $589.20M $564.00M
Deferred Revenue $553.00M $627.70M $458.90M $477.90M $442.00M
Total Current Liabilities $4.37B $3.94B $3.42B $3.14B $3.93B
Long-term Debt $1.99B $1.98B $1.98B $1.98B $1.98B
Other Non-current Liabilities $2.02B $1.57B $854.10M $638.00M $680.20M
Total Liabilities $9.30B $8.41B $7.11B $6.55B $6.67B
Retained Earnings $35.80B $31.67B $27.26B $23.31B $18.97B
Treasury Stock - - - - $8.26B
Total Stockholders Equity $31.26B $29.35B $25.97B $22.66B $18.77B
Total Liabilities & Equity $40.56B $37.76B $33.08B $29.21B $25.43B
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $4.50B $4.50B $4.41B $3.95B $4.34B $8.08B
Depreciation & Amortization $932.60M $543.70M $482.90M $421.00M $341.40M $286.20M
Stock-based Compensation $1.76B $993.70M $982.80M $885.00M $725.00M $601.70M
Deferred Income Tax - $-785.40M $-757.30M $-837.80M - -
Change in Receivables $-1.79B $-498.10M $554.00M $338.80M $-707.80M $1.93B
Change in Inventory $622.40M $275.30M $619.70M $271.70M $696.50M $494.30M
Operating Cash Flow $8.21B $4.98B $4.42B $4.59B $5.01B $7.08B
Capital Expenditure $1.58B $898.40M $755.90M $718.60M $590.10M $551.90M
Acquisitions - $3.30M $16.50M $54.90M $230.30M -
Purchases of Investments $18.89B $10.96B $16.62B $11.65B $7.49B $7.05B
Investing Cash Flow $-428.10M $-629.10M $-2.47B $-3.19B $-3.78B $-5.38B
Stock Issued $788.60M $635.90M $1.47B $1.15B $1.52B $1.67B
Stock Repurchased $6.58B $3.44B $2.60B $2.23B $2.08B $1.65B
Dividends Paid $650.50M $370.30M - - - -
Financing Cash Flow $-7.02B $-3.72B $-2.20B $-1.79B $-1.01B $-1.01B
Net Change in Cash $765.30M $634.70M $-248.80M $-381.60M $221.30M $690.80M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $3.75B - $10.46B -
Operating Expenses $2.73B - $7.76B -
Research & Development $1.48B - $4.22B -
Selling General & Admin $657.80M - $1.93B -
Operating Income $1.03B - $2.70B -
Interest Expense $19.30M - $31.60M -
Other Income/Expense $755.80M - $1.52B -
Income Before Tax $1.76B - $4.19B -
Income Tax Expense $303.30M - $526.70M -
Net Income $1.46B $1.43B $3.66B -
Basic EPS 14.09 - 34.83 -
Diluted EPS 13.62 - 33.61 -
Basic Shares Outstanding $103.60M - $105.10M -
Diluted Shares Outstanding $107.20M - $108.90M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $2.51B $2.49B
Short-term Investments $5.94B $6.52B
Accounts Receivable $5.69B $6.21B
Inventory $3.25B $3.09B
Other Current Assets $595.60M $349.20M
Total Current Assets $17.98B $18.66B
Intangible Assets $1.38B $1.15B
Long-term Investments $10.29B $8.90B
Other Non-current Assets $1.67B $1.14B
Total Assets $40.17B $37.76B
Accounts Payable $903.80M $789.50M
Deferred Revenue $545.60M $627.70M
Total Current Liabilities $4.43B $3.94B
Long-term Debt $1.99B $1.98B
Other Non-current Liabilities $1.86B $1.57B
Total Liabilities $9.21B $8.41B
Retained Earnings $35.05B $31.67B
Total Stockholders Equity $30.96B $29.35B
Total Liabilities & Equity $40.17B $37.76B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $1.46B $1.43B $3.66B -
Depreciation & Amortization - - $398.70M -
Stock-based Compensation - - $744.40M -
Change in Receivables - - $-549.30M -
Change in Inventory - - $277.40M -
Operating Cash Flow - - $3.81B -
Capital Expenditure - - $649.70M -
Acquisitions - - $3.00M -
Purchases of Investments - - $8.91B -
Investing Cash Flow - - $-849.40M -
Stock Issued - - $132.40M -
Stock Repurchased - - $2.77B -
Dividends Paid - - $277.60M -
Financing Cash Flow - - $-2.94B -
Net Change in Cash - - $24.10M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...